Sold Out
Book Categories |
Contributors | ||
Preface | ||
1 | Neuroleptic-induced movement disorders: historical perspective | 3 |
2 | Aging and tardive dyskinesia | 13 |
3 | Gender as a factor in the development of tardive dyskinesia | 26 |
4 | The Yale tardive dyskinesia study: a prospective incidence study among long-term outpatients | 41 |
5 | Vulnerability to tardive dyskinesia in schizophrenia: an exploration of individual patient factors | 56 |
6 | Tardive dyskinesia and affective disorder | 69 |
7 | Diabetes mellitus and tardive dyskinesia | 82 |
8 | Other factors in the development of tardive dyskinesia | 99 |
9 | Neuroleptic treatment and tardive dyskinesia | 104 |
10 | Anticholinergic drugs as factors in the development of tardive dyskinesia | 117 |
11 | Neurochemistry of the basal ganglia | 129 |
12 | A reanalysis of the dopamine theory of tardive dyskinesia: the hypothesis of dopamine D[subscript 1]/D[subscript 2] imbalance | 141 |
13 | Tardive dyskinesia and phenylalanine metabolism: risk-factor studies | 161 |
14 | Neuroendocrinological studies of tardive dyskinesia | 175 |
15 | Cognitive deficits and tardive dyskinesia | 196 |
16 | Studies of tardive dyskinesia using computed tomography and magnetic-resonance imaging | 207 |
17 | Rodent and other animal models of tardive dyskinesia during long-term neuroleptic-drug administration: controversies and implications for the clinical syndrome | 225 |
18 | Instrument measurements of tardive dyskinesia | 241 |
19 | Cultural aspects of tardive dyskinesia in Asia | 259 |
20 | Tardive dyskinesia in North America and the Middle East | 267 |
21 | Tardive dyskinesia in Europe | 274 |
22 | Role of ethnicity in the development of tardive dyskinesia | 298 |
23 | Tardive dyskinesia in children and adolescents | 311 |
24 | Drug-induced parkinsonism | 341 |
25 | Clinical aspects of neuroleptic-induced dystonia | 381 |
26 | Tardive dystonia | 395 |
27 | Tardive akathisia | 409 |
28 | Development of novel antipsychotic drugs with reduced extrapyramidal side effects | 427 |
29 | GABAergic treatments for tardive dyskinesia | 454 |
30 | Using biofeedback to train suppression of the oral-lingual movements of tardive dyskinesia | 470 |
Index | 484 |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionNeuroleptic-induced Movement Disorders: A Comprehensive Survey
X
This Item is in Your InventoryNeuroleptic-induced Movement Disorders: A Comprehensive Survey
X
You must be logged in to review the productsX
X
X
Add Neuroleptic-induced Movement Disorders: A Comprehensive Survey, The most widely prescribed group of psychotropic drugs, neuroleptics are indispensable in the management of a majority patients with schizophrenia, as well as other psychoses, yet they are associated with troublesome adverse effects, of which movement dis, Neuroleptic-induced Movement Disorders: A Comprehensive Survey to the inventory that you are selling on WonderClubX
X
Add Neuroleptic-induced Movement Disorders: A Comprehensive Survey, The most widely prescribed group of psychotropic drugs, neuroleptics are indispensable in the management of a majority patients with schizophrenia, as well as other psychoses, yet they are associated with troublesome adverse effects, of which movement dis, Neuroleptic-induced Movement Disorders: A Comprehensive Survey to your collection on WonderClub |